3.74 USD
↘ 0.15 (3.86%)AT CLOSE (11:59 AM EDT)
Ardelyx, Inc.
ARDXNASDAQ • USD
3.78
↗ 0.03 (0.94%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
3.78
↗ 0.03 (0.94%)
Market: CLOSED
Shares of Ardelyx, Inc. (ARDX) are trading at $3.74. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, ARDX appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Aug 24, 2026.
Open?$3.88
High?$3.89
Low?$3.73
Prev. Close?$3.89
Volume?5.2M
Avg. Volume?4.1M
VWAP?$3.77
Rel. Volume?1.26x
Bid / Ask
Bid?$3.25 × 100
Ask?$4.28 × 100
Spread?$1.03
Midpoint?$3.77
Valuation & Ratios
Market Cap?1.0B
Shares Out?249.2M
Float?243.2M
Float %?97.6%
P/E Ratio?N/A
P/B Ratio?6.74
EPS?-$0.22
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
Address
34175 ARDENWOOD BLVD.
FREMONT, CA 94555
Phone: 510-745-7047
FREMONT, CA 94555
Phone: 510-745-7047
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?12
Z-Score?4
Momentum?75
Short Sent.?48
Piotroski F-Score?2/9Weak
Altman Z-Score?0.20Distress
Confidence?55%Low
Short InterestVery High
Short % of Float?10.79%High
Short Interest?26.2M
Days to Cover?11.0
Free Float243.2M
Avg Daily Volume2.4M
Settlement Date2026-07-31
Financial Health
Current Ratio?3.34Strong
Quick Ratio?3.15Strong
Cash Ratio?0.74Adequate
Debt/Equity?1.69High
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score92/100
P/E?N/A▾
P/B?6.74FAIR▾
Peers100
S&P28
P/S?2.23CHEAP▾
Peers100
S&P62
P/FCF?N/A▾
EV/EBITDA?-36.1CHEAP▾
S&P97
EV/Sales?2.57CHEAP▾
Peers100
S&P67
Returns & Efficiency
ROE?-37.4%WEAK▾
S&P3
ROA?-9.7%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-17919000
Enterprise Value?$1.2B
Fundamentals ratios updated end of day